Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

NCT00227422 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: Mencevax ACWY

Sponsor

GlaxoSmithKline